reading your post one would think this company owns exenatide and has fda approval for the reformulated drug,they have neither and nxs have several products fda approved for sale already this company has an idea you are misleading people
Ann: Invex Therapeutics Lists on ASX, page-15
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.237M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15641 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 14244 | 1 |
View Market Depth
| Last trade - 11.03am 08/10/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable